Exercise of Share Options and Total Voting Rights
29 April 2025
Marlowe plc
("Marlowe" or the "Group")
Exercise of Share Options and TVR
Marlowe plc ("Marlowe" or the "Group"), the leader in business-critical services, announces that, as a result of an exercise of employee share options, application has been made for 3,733 new ordinary shares of 50 pence each in the Company (the "New Ordinary Shares") to be admitted to trading on AIM.
The New Ordinary Shares will rank pari passu with the Company's existing ordinary shares and it is expected that admission will occur at 8.00 a.m. on 30 April 2025.
Following admission of the New Ordinary Shares, the Company's issued ordinary share capital will comprise 78,522,547 ordinary shares, none of which are held in treasury. Therefore, the total number of ordinary shares with voting rights in Marlowe following admission will be 78,522,547.
The above figure of 78,522,547 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.
|
For further information: |
|
|
|
|
|
Marlowe plc |
|
|
Lord Ashcroft, Interim Non-Executive Chair Adam Councell, Chief Financial Officer Benjamin Tucker, Head of Group Reporting
|
www.marloweplc.com Tel: +44 (0)20 3813 8498
|
|
Cavendish Capital Markets Limited (Nominated Adviser & Broker) |
|
|
Ben Jeynes George Lawson |
Tel: +44 (0)20 7220 0500 |
|
|
|
|
FTI Consulting |
|
|
Nick Hasell Alex Le May |
Tel: +44 (0)20 3727 1340 |
About Marlowe plc
Marlowe is a leader in business-critical services which ensures compliance with strict regulations and insurance requirements across Fire Safety & Security and Water & Air Hygiene. The Group has a national footprint and serves approximately 27,000 customers across office complexes, high streets & leisure facilities, manufacturing plants and industrial estates, and include thousands of SMEs, local authorities, facilities management providers, multi-site NHS trusts and FTSE 100 companies.
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 8 hours ago Luceco
- 8 hours ago Helios Towers
- 8 hours ago Wise Class A
- 9 hours ago EDX Medical Group Plc
- 9 hours ago Naked Wines